Omega-3 fatty acids supplementation for HIV patients.

Completed

• Conditions: HIV patients on antiretroviral therapy

• Registration Number: NL-OMON20494
• Lead Sponsor: FAPESP - The State of São Paulo Research Foundation

Brief Summary

/A

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 28 February 2024

Recruitment & Eligibility

• Status: Completed
• Sex: Not specified
• Target Recruitment: 120

Inclusion Criteria

1. Adults (20-64 years);

2. Stable antiretroviral therapy for at least 3 months;

Exclusion Criteria

1. Use of fibrates and/or estatins;

2. Use of nutritional supplementation (vitamins and minerals), metformin and or anticoagulant;

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
1. Triglycerides;<br /><br>2. Total cholesterol and fractions (VLDL, LDL, HDL);<br /> <br>3. Apolipoprotein A1;<br /><br>4. Apolipoprotein B;<br /><br>5. High sensible C-reactive protein;<br /><br>6. Tumor necrosis factor-alpha;<br /><br>7. Interleukin 6;<br /><br>8. Interleukin-1beta;<br /><br>9. Ferritin;<br /><br>10. Fibrinogen;<br /><br>11. Von Willebrand factor.

Secondary Outcome Measures

Name	Time	Method
1. Lymphocytes T count (CD4 and CD8);<br /><br>2. Viral load;<br /><br>3. Fasting glycaemia;<br /><br>4. Insulin;<br /><br>5. Transferrin;<br /><br>6. Haemogram;<br /><br>7. Glutamic-oxalacetic transaminase;<br /><br>8. Glutamic-pyruvic transaminas;<br /><br>9. Creatinine;<br /><br>10. BMI;<br /><br>11. Waist circumference;<br /><br>12. Hip circumference;<br /><br>13. Neck circumference.